Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Update on Metastatic Squamous Non-Small Cell Lung Cancer
EP. 1: EGFR & ALK/ROS1 Testing in Squamous NSCLC
February 21st 2017
EP. 2: PD-L1 Testing in Squamous NSCLC
February 21st 2017
EP. 3: Pembrolizumab in Newly Diagnosed Squamous NSCLC
February 21st 2017
EP. 4: Toxicities Associated with Anti-PD-1 Immunotherapy
February 21st 2017
EP. 5: Pseudoprogression on Immunotherapy in Squamous NSCLC
February 21st 2017
EP. 6: Promising Immunotherapy Trials in Squamous NSCLC
February 21st 2017
EP. 7: Chemotherapy for Newly Diagnosed Squamous NSCLC
February 21st 2017
EP. 8: Maintenance Therapy for Squamous NSCLC
February 21st 2017
EP. 9: Choosing Second-Line Therapy for Squamous NSCLC
February 21st 2017
EP. 10: Further Sequencing in Squamous NSCLC
February 21st 2017
EP. 11: EGFR-Targeted Therapy for Squamous NCSLC
February 21st 2017
EP. 12: Final Thoughts on Squamous NSCLC Research
February 21st 2017
x
